HDIT/HCT is a new medical approach that is going to benefit the patients and make the work of the neurologist like Dr Shiva Vasishta easier. The treatment will induce remission of the Multiple Sclerosis.
Multiple Sclerosis is an autoimmune disease where your immune system attacks the Central Nervous System. If this happens, you will experience chronic pain, weakness and speech difficult. The condition will worsen as the years go by and can lead to disability.
With the new medical condition, neurologists will be in a position to reduce the long-term remission. The patients will get a high dose of immunosuppressive therapy, and this will be followed by a stem transplant using the patient’s blood-forming cells.
There was a five-year trial on the treatment done on different patients. 69% of the patients in the trial period reported a decrease in MS. They also said they did not experience a progression of disability or a relapse
The study was done by the National Institute of Allergy and Infectious Disease, and it indicated that this treatment could produce better results than the long term conditions. Even though the current research that was done indicate that the treatment is safe, more research is still needed to check on the associated benefits and risks if any.
About Dr Shiva Vasishta
Dr Shiva Vasishta is a neurologist, and his patients are set to benefit from this treatment. He has over 30 years of experience in the field, and that is what makes him an expert on the subject.
Dr Shiva Vasishta graduated from the Government Medical College with a Medical Degree. He is one of the doctors who practice neurology at the Kennedy University Hospital. He practices at the Eastern Neurodiagnostic Associates.
Dr Shiva Vasishta also specialises in psychiatry.